肾康注射液对慢性肾功能衰竭患者肾功能影响的临床研究  

Clinical Research of Improvement of Renal Function in Patients with Chronic Renal Failure by Shenkang Injection

作　　者：马振 杨桥榕 

机构地区：[1]广州市中西医结合医院,广东广州510800

出　　处：《中医学报》2013年第6期884-885,共2页Acta Chinese Medicine

基　　金：广东省中医药局科研课题(编号:20121010)

摘　　要：目的:探讨肾康注射液对慢性肾功能衰竭患者的肾功能改善状况。方法:将56例明确诊断为慢性肾功能衰竭的患者按随机数字表单盲法随机分为肾康组和尿毒清组。肾康组采用肾康注射液静脉注射;尿毒清组中成药尿毒清口服治疗。观察4周,记录患者肌酐、尿素氮、光抑素C、24h尿蛋白定量及临床症状。结果:两组疗效比较未见显著差异。治疗前两组血肌酐、尿素氮、光抑素C的比较,无显著性差异(P>0.05);肾康组及尿毒清组治疗前后对比差异均有统计学意义(P<0.05)。结论:肾康注射液可以改善慢性肾功能衰竭患者肾功能。Objective：To investigate the improvement of renal function in patients with chronic renal failure by Shenkang Injection.Methods：56 cases of patients clearly diagnosed with chronic renal failure patients were randomly divided into shenkang group and niaoduqing group according to random number table single-blind method.The shenkang group was treated with Shenkang Injection intravenous injection,and the niaoduqing group was given oral Niaoduqing Granule.Observation of 4 weeks,serum creatinine（SCr）,blood urea nitrogen（BUN）,CysC,24 hours urinary protein quantitative and clinical symptoms of patients were recorded.Results：Comparison of the total curative effect of the two groups had no significant difference.The comparisons of SCr,BUN and CysC of the two groups before treatment showed that the differences were no significant statistical significance（P0.05）.The comparisons of SCr,BUN,and CysC separately in the shenkang group and niaoduqing group before and after treatment both were statistically significant（P0.05）.Conclusion：Shenkang Injection can improve renal function of patients with chronic renal failure.

关 键 词：慢性肾功能衰竭 肾功能改善 肾康注射液 尿毒清 降逆泄浊 益气活血 通腑利湿 

分 类 号：R259.925[医药卫生—中西医结合]